Working…
COVID-19 is an emerging, rapidly evolving situation.
Get the latest public health information from CDC: https://www.coronavirus.gov.

Get the latest research information from NIH: https://www.nih.gov/coronavirus.
ClinicalTrials.gov
ClinicalTrials.gov Menu

Clinical Pediatric Pneumonia Score in Critically Ill Children

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT02139384
Recruitment Status : Withdrawn (The study was withdrawn due to inability to enroll patients in a timely fashion.)
First Posted : May 15, 2014
Last Update Posted : April 25, 2017
Sponsor:
Information provided by (Responsible Party):
Loma Linda University

Brief Summary:
The purpose of the study is to create a clinical pneumonia tool that can be used to predict the cause of community-acquired pneumonia, which is a lung infection that began outside of the hospital in critically ill children therefore limiting unnecessary antibiotic use. The investigators will enroll critically ill children admitted with acute respiratory failure and suspected pneumonia. Each patient will receive a clinical pneumonia score blinded from culture and respiratory viral panel results. All care after samples obtained will be at the discretion of the PICU team. The investigators believe that our clinical pneumonia scale with procalcitonin will accurately designate viral from bacterial etiologies.

Condition or disease
Community Acquired Pneumonia

Layout table for study information
Study Type : Observational
Actual Enrollment : 0 participants
Observational Model: Case-Only
Time Perspective: Prospective
Official Title: Development of a Clinical Pediatric Pneumonia Score in Critically Ill Children Admitted With Acute Respiratory Failure
Study Start Date : August 2012
Actual Primary Completion Date : January 2013
Actual Study Completion Date : January 2013

Resource links provided by the National Library of Medicine

MedlinePlus related topics: Pneumonia




Primary Outcome Measures :
  1. Can our proposed pneumonia score distinguish community acquired bacterial pneumonia from community acquired viral pneumonia [ Time Frame: 6 months ]


Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Layout table for eligibility information
Ages Eligible for Study:   up to 21 Years   (Child, Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Study Population
critically ill children admitted the the LLU PICU with acute respiratory failure with suspected community-acquired pneumonia
Criteria

Inclusion Criteria:

  • All intubated pediatric patients
  • Age 1 day to 21 years
  • Admitted to the LLUCH PICU with suspected pneumonia for the next 6 months
  • Have received antibiotics for less than 12 hours
  • Have been intubated for less than 24 hours
  • Patients must be English or Spanish speaking for consent purposes.

Exclusion Criteria:

  • Patients who have received antibiotics for greater than 12 hours
  • Patients who have been intubated for greater than 24 hours
  • Patients who are unable to tolerate non-bronchoscopic bronchoalveolar lavage

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT02139384


Locations
Layout table for location information
United States, California
Loma Linda University Children's Hospital
Loma Linda, California, United States, 92354
Sponsors and Collaborators
Loma Linda University
Investigators
Layout table for investigator information
Principal Investigator: Cynthia Tinsley, M.D. Loma Linda University
Layout table for additonal information
Responsible Party: Loma Linda University
ClinicalTrials.gov Identifier: NCT02139384    
Other Study ID Numbers: 5110327
First Posted: May 15, 2014    Key Record Dates
Last Update Posted: April 25, 2017
Last Verified: April 2017
Keywords provided by Loma Linda University:
procalcitonin
community acquired pneumonia
pneumonia score
Additional relevant MeSH terms:
Layout table for MeSH terms
Pneumonia
Lung Diseases
Respiratory Tract Diseases
Respiratory Tract Infections